Orbita, a provider of conversational AI-enabled chatbots for the healthcare industry, secured $9 million in Series A financing round.
The company plans to use the new funds to expand its reach as it supports engagement and marketing in the life sciences market.
Orbita says that in the past few months, it has responded to an unprecedented number of requests related to COVID-19, from both existing and prospective customers worldwide.
More recently, Orbita launched a COVID-19 chatbot that automates symptom-screening and question-answering services using content sourced from the U.S. Centers for Disease Control and Prevention (CDC). The company has since released additional capabilities to target the pandemic’s evolving demands, including automated health monitoring for patients, employees, and other at-risk populations.
Philips Health Technology Ventures and HealthX Ventures co-led the round with participation from Cultivation Capital and Newark Venture.
“Philips views conversational AI through voice and chatbot as an important future enabler to drive patient experience and clinical efficiency, especially in light of the current COVID-19 pandemic,” said Rich Wilmot, Head of Philips Health Technology Ventures Global. “We aim to partner with and invest in promising digital health companies complementary to Philips strategic initiatives and Orbita has established itself as a leading innovator in the industry with products and solutions that are enterprise-ready, pressure tested, and highly relevant to the pressing needs of healthcare providers.”
Orbita also offers an end-to-end HIPAA-compliant, the voice-enabled virtual assistant – OrbitaAssist, which facilitates hands-free communication for patients and care teams with back-end analytics alerts, and escalation, along with electronic health records (EHRs) integration. OrbitaAssist developed in partnership with nurses, and it aims to eliminate unnecessary bedside trips by confirming patient requests, combating social isolation, and routing patient and care worker requests.
Boston-based Orbita has raised over $16 million since its founding in 2015.
Early this year, Buoy Health, an AI-powered chatbot app that allows users to check health symptoms, secured $5 million investment from Cigna Ventures, a corporate venture arm of Cigna Corporation.”
Image credit: Orbita